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Dopamine is an important neuromodulator involved in reward-processing, movement
control, motivational responses, and other aspects of behavior in most animals. In honey
bees (Apis mellifera), the dopaminergic system has been implicated in an elaborate
pheromonal communication network between individuals and in the differentiation of
females into reproductive (queen) and sterile (worker) castes. Here we have identified
and characterized a honey bee dopamine transporter (AmDAT) and a splice variant
lacking exon 3 (AmDAT1ex3). Both transcripts are present in the adult brain and
antennae as well as at lower levels within larvae and ovaries. When expressed separately
in the Xenopus oocyte system, AmDAT localizes to the oocyte surface whereas the
splice variant is retained at an internal membrane. Oocytes expressing AmDAT exhibit a
12-fold increase in the uptake of [3H]dopamine relative to non-injected oocytes, whereas
the AmDAT1ex3-expressing oocytes show no change in [3H]dopamine transport.
Electrophysiological measurements of AmDAT activity revealed it to be a high-affinity,
low-capacity transporter of dopamine. The transporter also recognizes noradrenaline
as a major substrate and tyramine as a minor substrate, but does not transport
octopamine, L-Dopa, or serotonin. Dopamine transport via AmDAT is inhibited by
cocaine in a reversible manner, but is unaffected by octopamine. Co-expression of
AmDAT and AmDAT1ex3 in oocytes results in a substantial reduction in AmDAT-
mediated transport, which was also detected as a significant decrease in the level
of AmDAT protein. This down-regulatory effect is not attributable to competition with
AmDAT1ex3 for ER ribosomes, nor to a general inhibition of the oocyte’s translational
machinery. In vivo, the expression of both transcripts shows a high level of inter-individual
variability. Gene-focused, ultra-deep amplicon sequencing detected methylation of the
amdat locus at ten 5′-C-phosphate-G-3′ dinucleotides (CpGs), but only in 5–10% of all
reads in whole brains or antennae. These observations, together with the localization
of the amdat transcript to a few clusters of dopaminergic neurons, imply that amdat
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methylation is positively linked to its transcription. Our findings suggest that multiple
cellular mechanisms, including gene splicing and epigenomic communication systems,
may be adopted to increase the potential of a conserved gene to contribute to lineage-
specific behavioral outcomes.
Keywords: biogenic amine, dopaminergic neurons, social behavior, heteromeric protein, spliced transporter, DNA
methylation
INTRODUCTION
Dopamine is a biogenic monoamine of special interest (Iversen
and Iversen, 2007). In both vertebrates and invertebrates, it
acts as a neurotransmitter in several distinct pathways operating
across various regions of the brain (Torres et al., 2003). It
has been implicated in motivation, reward, addiction, attention,
salience, and movement control. Deficiencies in the neuronal
dopaminergic system result in debilitating diseases in humans
(Iversen and Iversen, 2007; Ashok et al., 2017; Mackie et al.,
2018), and mutants of Drosophila melanogaster lacking the ability
to synthesize dopamine show reduced activity, extended sleep-
time, locomotor deficits, abnormalities in arousal and choice,
and are hypophagic (Riemensperger et al., 2011). In insects,
dopamine is also involved in post-mating pheromone responses
and is a critical substrate for cuticle pigmentation and hardening
(Cichewicz et al., 2017).
The dopaminergic system has been a focus of studies on the
evolution of social behavior in honey bees (Apis mellifera) and
other eusocial insects (Blenau and Erber, 1998; Scheiner et al.,
2006; Beggs et al., 2007; Okada et al., 2015). Several aspects
of reproduction, behavioral maturation, and social dominance
in eusocial societies have been associated with biogenic amines
(Harris and Woodring, 1995; Harano et al., 2005, 2008; Okada
et al., 2015). In an evolutionary context, a compelling idea
is that biogenic amines and their receptors have been co-
opted to control physiology and behaviors in insects leading
to the emergence of eusocial societies (Kamhi et al., 2017).
Studies by Mercer and colleagues have revealed that dopamine
plays a critical role in social communication via the peripheral
modulation of worker bee responses to the queen mandibular
pheromone (QMP) (Beggs et al., 2007; Vergoz et al., 2007).
A plausible mechanism by which the queen bee influences the
colony is via QMP components such as homovanillyl alcohol,
which structurally resembles dopamine (Jarriault and Mercer,
2012). One hypothesized benefit to the bee society from this
blocking effect is the neutralization of any unpleasant perception
of the high levels of QMP. This idea is supported by the
observation that only very young bees are attracted to the queen,
whereas older nurses and foraging individuals are repelled by
QMP (Jarriault and Mercer, 2012).
Like other neuromodulators, dopamine exerts its action via
a molecular system composed of G protein-coupled receptors
and transporters, the role of which is to control dopamine
storage, release, and reuptake (Torres et al., 2003). In Apis,
AmDOP1–3 have been characterized in detail and are known
to be expressed in the brain and antennae (Blenau et al.,
1998; Humphries et al., 2003; Mustard et al., 2003; Beggs
et al., 2005; Beggs and Mercer, 2009). By contrast, nothing is
known about the proteins responsible for dopamine transport
in this species, or how these proteins regulate the timing
and strength of neurotransmission as well as the pre-synaptic
pool of dopamine. In other organisms, dopamine released into
the synaptic cleft is deposited back into the surrounding cells
primarily by transporters of the solute carrier 6 (SLC6) family
(also known as the neurotransmitter:sodium symporter family,
T.C. 2.A.22). A number of SLC6 proteins have been shown
to transport one or more monoamines, including dopamine,
serotonin, noradrenaline, octopamine, and tyramine (Bröer and
Gether, 2012). Both the vertebrate and invertebrate nervous
systems feature dopamine and serotonin, whereas noradrenaline
is replaced in invertebrates with octopamine and tyramine
(Roeder, 2005). The monoamine transporters of the SLC6 family
typically display high affinities for their substrates (which are
present at very low levels in the synapses) and become saturated
at low monoamine concentrations (Bröer and Gether, 2012).
Moreover, many of the insect and mammalian monoamine
transporters are sensitive to cocaine, a neurotoxin that acts as an
effective plant defense compound by disrupting motor control
in herbivores, but which is rewarding and highly addictive in
humans (Barron et al., 2009; Eriksen et al., 2009). Cocaine acts
by binding reversibly to a site overlapping, but not identical to,
the conserved substrate binding-site of monoamine transporters,
thereby inhibiting the reuptake of released monoamines and
prolonging their synaptic effect (Beuming et al., 2008). However,
despite the substantial research efforts driven by the public health
costs of cocaine, it is currently unclear which of the monoamine
transporter(s) are responsible for mediating the effect of cocaine.
Dopamine and serotonin transporters from insects are
convenient models that have already provided important insights
into the action of cocaine, and of other drugs, on these
neurotransmitter systems (Porzgen et al., 2001; Sandhu et al.,
2002). Insect monoamine transporters are also important
proteins in themselves given their potential to serve as novel
targets for harnessing or controlling insects to achieve economic
and/or human health gains (Caveney and Donly, 2002; Malutan
et al., 2002). Here we have identified and characterized a
honey bee dopamine transporter (AmDAT) as well as a novel
splice variant (AmDAT1ex3) of this protein. A broad array
of assays and database resources were utilized to gain an
understanding of (i) the structure, methylation, and transcription
of the amdat gene, (ii) the functions of the AmDAT and
AmDAT1ex3 proteins, and (iii) the interactions of AmDAT with
several monoamines and cocaine. Taken together, our findings
reveal a complex picture for AmDAT and its splice variant,
including novel properties that may play a role in animal social
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interactions. The insights presented here suggest that multiple
levels of cellular regulation, including epigenomic modifications
and alternative splicing, may be modulating AmDAT activity
to generate complex phenotypic and behavioral outcomes.
As such, this work provides a foundation for unraveling
how these regulatory networks recruit relatively simple and
highly conserved molecules, such as neurotransmitters, to
perform lineage-specific roles (Miklos and Maleszka, 2011;
Maleszka, 2016).
EXPERIMENTAL PROCEDURES
Compounds Used in This Study
[3H]dopamine and [3H]hypoxanthine were purchased from
PerkinElmer. Dopamine, octopamine, L-Dopa, tyramine,
serotonin, noradrenaline and cocaine were purchased from
Sigma-Aldrich. Solutions containing monoamines were
prepared fresh prior to each experiment to prevent oxidation
of the monoamines.
Cloning of the Honey Bee DAT Gene and
Other Molecular Methods
The strategy employed to clone the full-length coding regions of
amdat and amdat1ex3 is shown in Supplementary Figure S1.
It involved adding a synthetic fragment to extend the missing
5-end of the longest clone recovered from the brain cDNA.
Recombinant plasmids harvested from liquid bacterial cultures
did not contain any non-synonymous polymorphisms in the
amdat sequence (Supplementary Table S1), indicating that it
was suitable for further in vitro characterization. Transcriptional
profiling was undertaken by qPCR as described previously
(Becker et al., 2016; Kucharski et al., 2016). Gene-focused DNA
methylation analyses were performed using amplicons generated
from bisulfite-converted brain and antennal DNAs followed
by ultra-deep sequencing on Illumina MiSeq platform (Wedd
et al., 2016). All experimental procedures, including honey bee
collections, are detailed in the Supplementary Material.
Generation of the Constructs for
Xenopus Oocyte Expression
The coding sequence of the Emerald Green Fluorescent
Protein (EmGFP) was amplified from the pJTITM R4 Dest
CMV N-EmGFP pA vector (Invitrogen) and inserted into
the oocyte expression vector pGEM-He-Juel. Sequences
encoding versions of AmDAT and AmDAT1ex3 tagged
with the human influenza hemagglutinin (HA) epitope were
synthesized by GenScript and inserted into pGEM-He-Juel.
A HA-tag was inserted into the second extracellular loop
of AmDAT via the introduction of the nucleotide sequence
gcaggagcttatccatacgatgttcctgactatgcagcaggagct between positions
495–496 of the AmDAT coding sequence (resulting in a HA-tag –
YPYDVPDYA – flanked by an “AGA” peptide spacer at each
end). This insertion point was selected because the presence of a
HA-tag at the equivalent position of human DAT (HsDAT) did
not affect the protein’s transport properties, expression, and/or
trafficking, nor did it interfere with the nearby N-glycosylation
sites (Sorkina et al., 2006; Bolan et al., 2007; Eriksen et al., 2009;
Rao et al., 2012). By contrast, the addition of three HA-tags
to the N-terminus of HsDAT was found to greatly diminish
its dopamine transport activity (Vecchio et al., 2014) and we
observed complete suppression of dopamine transport activity
when two HA-tags were added to the N-terminus of AmDAT
(data not shown). The HA-tagged forms of AmDAT and
AmDAT1ex3 are hereon referred to as HAEL2-AmDAT and
HAEL2-AmDAT1ex3, respectively.
Preparation of cRNA
The plasmids were linearized with NotI or SalI (ThermoFisher
Scientific) and 5′-capped complementary RNA (cRNA) was
transcribed in vitro using the mMessage mMachine T7 kit
(Ambion) and then purified with the MEGAclear kit (Ambion).
The samples were adjusted to the desired cRNA concentration
using RNase-free elution buffer (Ambion) and the quality of the
cRNA assessed via agarose gel electrophoresis.
Harvest, Preparation, and Microinjection
of Xenopus Oocytes
Oocytes were harvested and prepared as described in full
elsewhere (van Schalkwyk et al., 2016). Briefly, sections of ovary
were harvested from adult female frogs (purchased from NASCO,
United States) via a minor surgical procedure and single, de-
folliculated oocytes were prepared using a mix of collagenase A
(Roche) and collagenase D (Roche). Stage V–VI oocytes were
microinjected with cRNA (10 ng per oocyte) encoding AmDAT,
AmDAT1ex3, HAEL2-AmDAT, or HAEL2-AmDAT1ex3. For the
expression of EmGFP and the Plasmodium falciparum nucleoside
transporter 1 (PfNT1), 15.4 fmol of cRNA was injected (equating
to 5 ng of EmGFP cRNA and 7.6 ng of PfNT1 cRNA). The oocytes
were stored at 16–18◦C in OR2+ buffer (82.5 mM NaCl, 2.5 mM
KCl, 1 mM MgCl2, 1 mM Na2HPO4, 5 mM HEPES, 1 mM CaCl2,
and 50 µg/mL penicillin-streptomycin; pH 7.8).
Immunofluorescence Analysis
Oocytes expressing HAEL2-AmDAT or HAEL2-AmDAT1ex3
were fixed and labeled with antibodies 3 days post-cRNA-
injection using a protocol detailed elsewhere (Richards et al.,
2016). A mouse anti-HA antibody (Sigma, cat. no. H9658) and
an Alexa Fluor 488 donkey anti-mouse antibody (Molecular
Probes, cat no. A21202) were used at concentrations of 1:100
and 1:500, respectively. At least two independent experiments
were performed (on oocytes from different frogs) for each oocyte
type, within which slices were examined from a minimum
of three oocytes.
Western Blot Analyses
The semi-quantification of HAEL2-AmDAT and HAEL2-
AmDAT1ex3 protein levels in preparations of oocyte
membranes was carried out using a protocol described in
detail elsewhere (Summers et al., 2014) with the following minor
modification: the final protein pellet was solubilized in 20 µL of a
solution comprising 3 M urea, 100 mM DTT, 1% (v/v) SDS, 5 mM
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Tris–HCl (pH 7.6), 2.5 mM NaCl, 0.25% (v/v) Triton X-100, and
32.5% (v/v) NuPage sample loading buffer (Life Technologies).
The levels of EmGFP protein were semi-quantified in extracts
prepared from whole oocytes using a method outlined elsewhere
(Marchetti et al., 2015), with the following minor modification:
after pelleting the oocyte yolk, a sample of the supernatant was
added to NuPage sample loading buffer (final concentration of
25% v/v) supplemented with 10 mM DTT. The protein samples
prepared from oocyte membranes (HAEL2-AmDAT and HAEL2-
AmDAT1ex3) or whole oocytes (EmGFP) were then separated
on a 4–12% Bis-Tris SDS-polyacrylamide gel (Life Technologies)
and transferred to a Protran 0.45 µm nitrocellulose membrane
(Amersham, GE Healthcare Life Sciences). The membranes
were probed with a mouse anti-HA antibody (concentration
of 1:2,000–1:4,000; Sigma-Aldrich, cat. no. H9658) or a mouse
anti-GFP antibody (concentration of 1:3,000; Invitrogen, cat. no.
MA5-15256), followed by a horseradish peroxidase-conjugated
goat anti-mouse antibody (1:10,000; Life Technologies, cat. no.
626520). The protein bands were detected by chemiluminescence
(Pierce), quantified using the Image J software (Schneider et al.,
2012), and expressed as a percentage of the protein band intensity
measured for the relevant control sample (i.e., oocytes expressing
only HAEL2-AmDAT, HAEL2-AmDAT1ex3, or EmGFP). Total
protein staining was used to evaluate sample loading and
efficiency of transfer; the membranes were rinsed with ultrapure
water, stained with the MemCodeTM reversible protein stain
kit (Pierce), and destained with ultrapure water. Densitometric
analysis was performed using Image Studio Lite version 5.2
software (LI-COR). At least three independent experiments
were performed (using oocytes from different frogs), and within
each experiment the measurements were averaged from two
independent replicates.
Radioisotope Transport Assays
The uptake into oocytes of [3H]dopamine (0.14 µM;
21.2 Ci/mmol) and [3H]hypoxanthine (1.5 µM; 30 Ci/mmol)
was measured 1–3 days post-cRNA-injection using a protocol
described previously (Richards et al., 2016). The [3H]dopamine
transport assays were conducted over 15 min at 27.5◦C and in the
presence of 0.86µM unlabeled dopamine. The [3H]hypoxanthine
transport assays were performed over 30 min at 27.5◦C. The
reaction buffer was either ND96 pH 6.0 ([3H]hypoxanthine
transport assays) or ND96 pH 7.4 ([3H]dopamine transport
assays) and contained 96 mM NaCl, 2 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2, and 10 mM Tris–base supplemented with either
10 mM MES (pH 6.0 buffer) or 10 mM HEPES (pH 7.4 buffer). In
all cases, at least three independent experiments were performed
(using oocytes from different frogs), and within each experiment
the measurements were made from 10 oocytes per treatment.
Electrophysiological Recordings
Electrophysiological recordings were conducted 3–5 days post-
cRNA-injection as described previously (Bröer, 2003; Böhmer
et al., 2005). Briefly, all steady-state recordings were made
with an Axon Geneclamp 500B amplifier (Axon Instruments).
Voltage clamp was routinely set to –50 mV, and data were
sampled at 3 Hz using pClamp 8.2 software (Axon Instruments).
Oocytes were chosen for recording when they had a resting
membrane potential –25 mV < Vm < –35 mV. ND96 pH
7.4 buffer (96 mM NaCl, 2 mM KCl, 1.8 mM MgCl2, 1 mM
CaCl2 and 5 mM HEPES, titrated to pH 7.4 with NaOH)
was used as the control solution for all electrophysiological
recordings, unless indicated otherwise. To measure currents
induced by various monoamines of interest, oocytes expressing
AmDAT were superfused with ND96 pH 7.4 buffer containing a
monoamine at a final concentration of 100 µM. After currents
reached a plateau, superfusion was switched back to ND96 to
observe reversibility of the currents. At least two independent
experiments were performed (using oocytes from different frogs),
and within each experiment the measurements were made from
8–11 oocytes per treatment.
Each datapoint or column in the Figures represents the activity
(mean ± SEM.) for eight to eleven AmDAT-expressing oocytes.
For all experiments bar octopamine inhibition, recordings
were conducted over 2 weeks, using oocytes prepared from
two different females, and the resulting data were pooled for
individual experiments. All raw values were normalized to the
first dopamine current in a recording.
Measurements of EmGFP Fluorescence
The fluorescence intensity of oocytes expressing EmGFP was
measured 1–3 days post-cRNA-injection. The oocytes were
transferred to separate wells of a clear 96-well plate (Corning)
and lysed in 50 µL of 20 mM Tris–HCl (pH 7.6) supplemented
with the cOmpleteTM EDTA-free protease inhibitor cocktail
(Roche). The fluorescence intensity was measured with a
TECAN Infinite M1000 PRO plate reader. The excitation and
emission wavelengths were 487 and 509 nm, respectively.
In all cases, at least three independent experiments were
performed (using oocytes from different frogs), and within
each experiment the measurements were made from ten
oocytes per treatment.
Statistics
Statistical comparisons were made using one-way analysis
of variance (ANOVA) in conjunction with Tukey’s multiple
comparisons test. A difference was considered statistically
significant if p < 0.05. Kinetic constants were derived from the
electrophysiology data by non-linear curve fitting to the allosteric
sigmoidal equation provided by Prism 5 (GraphPad).
RESULTS
Computational Identification of a
Putative Dopamine Transporter in the
Honey Bee Genomic and Transcriptomic
Databases
We used the genomic assemblies and transcriptomic
datasets available for the honey bee to extract all putative
transporters belonging to the SLC6 family. The honey
bee genome appears to encode 14 members of this family,
including a protein (designated GB40867 in genome assembly
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FIGURE 1 | The honey bee dopamine transporter (AmDAT). (A) amdat gene model showing the exon and intron junctions of the full-length transcript and its spliced
variant, the positions of methylated CpGs (black lollipops), and the regions of four amplicons (top) used for methylation analysis (see the main text and
Supplementary Material for more details). The only methylated CpG uncovered by whole-genome methylomics is in exon 11. Protein coding exons are shown in
green. (B) The predicted topologies of AmDAT (643 residues; shown in blue) and its splice variant AmDAT1ex3 (598 residues; shown in orange). AmDAT1ex3 lacks
transmembrane domain 2 (TMD2) as well as the following cytosolic loop, resulting in an elongated TMD3. The affected region is shaded dark orange. The orientation
of the N-terminus and TMD1 are predicted by TMpred and SPOCTOPUS to be inverted relative to the full-length protein.
V.4.5) that shows a high level of sequence similarity to the
Drosophila melanogaster dopamine transporter (DmDAT;
Supplementary Table S2). The amdat gene model is shown in
Figure 1A. AmDAT shows 71% identity and 85% similarity to
DmDAT, and 50% identity and 71% similarity to the human
noradrenaline/dopamine transporters.
The expression of amdat in different situations was evaluated
by compiling a number of Apis mellifera transcriptomic
databases. Consistent with its putative role in the reuptake of
dopamine transport from the synaptic cleft, amdat is expressed
in brains or heads of both adult and larval stages as well as in
adult antennae. Transcripts are also present in libraries derived
from other tissues, including queen ovaries and various glands
(Supplementary Table S3).
Importantly, we detected an alternatively spliced transcript
of amdat in libraries derived from honey bee brains. The
transcript is missing exon 3, but maintains the reading frame
of the coding sequence. The resulting protein, designated
AmDAT1ex3, would lack transmembrane domain 2 (TMD2)
as well as the following linker region, and may consequently
possess an elongated TMD3 (Figure 1B). Furthermore, the
orientation of the N-terminus and TMD1 of AmDAT1ex3
is predicted by TMpred and SPOCTOPUS (Hofmann and
Stoffel, 1993; Viklund et al., 2008) to be inverted relative to
these segments of the full-length protein. Given its significantly
deformed topology, it seemed unlikely that AmDAT1ex3
would function as a transporter. Nevertheless, its presence in
several transcript libraries derived from honey bees collected
in different geographical areas suggests that it serves a
physiological role. All NCBI datasets in which amdat1ex3
has been found are listed in Supplementary Table S3. In
addition to brain, antennae, and ovaries, amdat1ex3 is present
in several glands.
Expression of AmDAT and AmDAT1ex3
in Xenopus Oocytes
We used the Xenopus oocyte expression system to assess the
transport activities of AmDAT and AmDAT1ex3. In both
cases, the expression of the desired protein was verified by
injecting oocytes with cRNA encoding a hemagglutinin (HA)-
tagged version of the protein (HAEL2-AmDAT and HAEL2-
AmDAT1ex3, respectively). Semi-quantitative western blot
analyses of oocyte membrane preparations with an anti-HA
antibody detected a band corresponding to ∼55 kDa for
HAEL2-AmDAT [predicted size of 72 kDa, noting that the
binding of SDS tends to accelerate the migration of membrane
transport proteins in SDS-PAGE (Rath et al., 2009)] and a band
corresponding to ∼50 kDa for HAEL2-AmDAT1ex3 (predicted
size of 67 kDa) (Figure 2A). These analyses also indicated
that HAEL2-AmDAT1ex3 was present at much lower levels
than HAEL2-AmDAT in the oocyte membrane preparations
(p< 0.001; Figure 2B). Total protein staining of the nitrocellulose
membranes confirmed this observation was not due to uneven
sample loading and/or uneven transferral of proteins from the
SDS-PAGE gel (Supplementary Figure S2).
The presence of HAEL2-AmDAT in the oocyte plasma
membrane was confirmed with an immunofluorescence
microscopy assay (Figure 2C). By contrast, HAEL2-AmDAT1ex3
was not detected at the oocyte surface, nor was it evident
immediately below the oocyte plasma membrane. Given that
antibodies will not penetrate into the yolk-sac laden interior of
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FIGURE 2 | Heterologous expression of AmDAT and AmDAT1ex3 in Xenopus oocytes. (A) Detection of HAEL2-AmDAT (∼55 kDa band indicated by black arrow)
and HAEL2-AmDAT1ex3 (∼50 kDa band indicated by black arrow) in oocyte membrane preparations. The samples were prepared on day 3 post-cRNA-injection,
separated on a SDS-polyacrylamide gel, and probed with a mouse anti-HA antibody. A preparation of membrane protein from non-injected oocytes (ni) probed with
the anti-HA antibody did not produce a band within this region. The image is representative of >3 independent experiments (performed using oocytes from different
frogs). (B) Semi-quantification of the HAEL2-AmDAT and HAEL2-AmDAT1ex3 proteins in the oocyte membrane. The intensity of the HAEL2-AmDAT1ex3 band was
expressed as a percentage of the band measured for HAEL2-AmDAT. The data are shown as the mean + SEM from six independent experiments (performed using
oocytes from different frogs), within which measurements were averaged from two replicates. (C) Immunofluorescence microscopy of Xenopus oocytes expressing
HAEL2-AmDAT or HAEL2-AmDAT1ex3. The oocyte plasma membrane lies over a band of granules known as the “pigment layer”. This layer in turn surrounds a
cytoplasm packed with yolk sacs and small endosomal- and lysosomal-type organelles. The expression of HAEL2-AmDAT resulted in a fluorescent band external to
the pigment layer, consistent with this protein being present in the oocyte plasma membrane. A fluorescent band was not detected in non-injected oocytes or in
oocytes expressing HAEL2-AmDAT1ex3, suggesting that the splice variant is retained at an intracellular membrane. The images are representative of at least two
independent experiments (performed using oocytes from different frogs), within which images were obtained from a minimum of 3 oocytes per oocyte type.
(D) Transport of dopamine via AmDAT and HAEL2-AmDAT. Measurements of [3H]dopamine uptake by oocytes expressing the non-tagged or HA-tagged forms of
AmDAT or AmDAT1ex3 were performed on day 3 post-cRNA-injection. Non-injected oocytes (ni) were included as the negative control. Dopamine uptake was
expressed as a percentage of that measured in oocytes expressing AmDAT. The data are the mean + SEM of 3–4 independent experiments (performed using
oocytes from different frogs), within which measurements were made from 10 oocytes per treatment. The capacities of HAEL2-AmDAT and HAEL2-AmDAT1ex3 for
dopamine transport did not differ significantly from those of their non-tagged counterparts (p > 0.05), consistent with the HA-tag exerting little or no effect upon the
functions of these proteins. ∗∗∗denotes a significant difference (p < 0.001) between the indicated treatments (one-way ANOVA).
the oocyte, this assay could not ascertain the localization of the
splice variant. However, the detection of HAEL2-AmDAT1ex3 in
oocyte membrane preparations (Figures 2A,B), and its absence
from the oocyte surface, suggests that the splice variant is
retained in an intracellular membrane.
The capacities of HAEL2-AmDAT and HAEL2-AmDAT1ex3,
as well as of the non-tagged proteins, to transport dopamine
were tested with a radioisotope uptake assay. The direction
of [3H]dopamine transport in these experiments was from the
extracellular medium (pH 7.4) into the oocyte cytosol, which
corresponds to the reuptake of dopamine from the presynaptic
cleft into the cytosol of dopaminergic neurons. The uptake
of [3H]dopamine by non-injected oocytes was very low; this
represented the background level of [3H]dopamine accumulation
(Figure 2D). Oocytes expressing AmDAT or HAEL2-AmDAT
showed a marked increase in [3H]dopamine transport relative to
non-injected oocytes (12.6 ± 0.6- and 12.3 ± 0.5-fold increases,
respectively; mean± SEM, n = 4–7; p< 0.001), with the inclusion
of the HA-tag having no effect on the protein’s ability to mediate
dopamine uptake (p > 0.05). By contrast, neither AmDAT1ex3
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nor HAEL2-AmDAT1ex3 caused an increase in the accumulation
of [3H]dopamine within oocytes (Figure 2D).
Transport Properties of AmDAT in
Xenopus Oocytes
The successful expression of AmDAT at the oocyte surface
enabled the use of electrophysiology to investigate the protein’s
transport properties. The substrate-specificity of AmDAT was
investigated by superfusing oocytes with seven potential
substrates in the following order: dopamine, octopamine,
L-Dopa, dopamine, tyramine, serotonin, noradrenaline, and
dopamine. All currents are expressed as a percentage of the
first dopamine current. The currents induced with octopamine
(0.5 ± 2.5; mean ± SEM, n = 11; p < 0.001), L-Dopa
(–0.9 ± 2.5; n = 10; p < 0.001), serotonin (6.6 ± 1.8; n = 11;
p < 0.001), and tyramine (44.9 ± 7.8; n = 9; p < 0.001) were
significantly smaller than the currents induced with dopamine
(Figure 3A). By contrast, the current induced with noradrenaline
(92.4 ± 4.8; n = 10; p > 0.05) was not significantly smaller
than that induced by dopamine. These results indicate that
dopamine and noradrenaline are major substrates of AmDAT,
with tyramine being a minor substrate. Octopamine, L-Dopa, and
serotonin do not appear to be substrates of AmDAT.
The kinetics of dopamine transport via AmDAT were
determined by superfusing oocytes with a series of dopamine
solutions of different concentrations. The superfusions were first
performed in decreasing order of concentration, after which the
same series was performed in reverse (and with the same oocyte).
The relationship between the dopamine-induced current and
the dopamine concentration is shown in Supplementary Figure
S3A. Non-linear regression was used to fit an allosteric sigmoidal
equation (a slightly modified version of the Hill equation) to the
normalized data. The values obtained for K0.5 (5.6 ± 3 µM)
FIGURE 3 | Transport properties of AmDAT in Xenopus oocytes. Measurements were conducted with oocytes expressing AmDAT on day 3 post-cRNA-injection.
The oocytes were held at a membrane potential of –50 mV and superfused with ND96 (pH 7.4) or ND96 (pH 7.4) containing different monoamines at a final
concentration of 100 µM. Each bar represents the mean and SEM of n = 11 oocytes (using oocytes from at least two different frogs). The data were normalised to
the current induced by 100 µM dopamine. ∗∗∗denotes a significant difference (p < 0.001) from the dopamine current at 100 µM (one-way ANOVA). (A) Substrate
specificity of AmDAT. (B) Inhibition of AmDAT by cocaine.
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and the Hill coefficient n (2.4 ± 0.2) indicate, respectively, that
AmDAT is a high-affinity, low-capacity transporter of dopamine
and that it forms a dimer and operates in a cooperative manner.
AmDAT Is Inhibited by Cocaine, but Not
by Octopamine
The interactions of cocaine and octopamine with AmDAT were
investigated by superfusing oocytes with solutions of dopamine,
the test compound, or a mixture of both dopamine and the test
compound. The pattern applied in these experiments (illustrated
in Supplementary Figure S3B) was designed to ascertain
whether the test compound was a substrate or an inhibitor of
AmDAT, and if the latter, whether binding to AmDAT was
reversible. All currents are expressed as a percentage of the first
dopamine current. Cocaine did not produce a significant current
in Am-DAT expressing oocytes (Figure 3B); the mean ± SEM
value for cocaine was 3.4 ± 1.7 (n = 11; p < 0.001). The
presence of cocaine decreased the current induced by dopamine
to 61.6 ± 4.9 (n = 10; p < 0.001), whereas octopamine was
without effect (data not shown). AmDAT-expressing oocytes that
had been superfused with cocaine or a dopamine + cocaine
mix retained their ability to produce dopamine-induced currents
(n = 10; p < 0.001), consistent with cocaine binding to
AmDAT in a reversible manner (Supplementary Figure S3B).
Together, the data indicate that AmDAT does not interact with
octopamine, and that cocaine is an inhibitor, but not a substrate,
of the transporter.
Characterization of AmDAT1ex3 in
Xenopus Oocytes
AmDAT1ex3 Reduces Dopamine Transport via
AmDAT
The inability of AmDAT1ex3 to transport [3H]dopamine
(Figure 2D) led us to investigate whether it may instead
function to regulate the activity of the full-length transporter.
The uptake of [3H]dopamine was measured in non-injected
oocytes (negative control) and in oocytes expressing AmDAT
(positive control) or AmDAT + AmDAT1ex3. Two unrelated
proteins – the Plasmodium falciparum nucleoside transporter
(PfNT1) and the Emerald Green Fluorescent Protein (EmGFP) –
were included as additional negative controls (neither protein
affects the permeability of oocytes to dopamine; Figure 4
and Supplementary Figure S4). AmDAT was also expressed
with PfNT1 or EmGFP to provide co-injection controls. We
found that co-expression of AmDAT1ex3 with AmDAT caused
a 33 ± 8% decrease in the AmDAT-mediated transport
of [3H]dopamine (mean ± SEM, n = 4; Figure 4 and
Supplementary Figure S4). Moreover, this effect was sustained
over a 3-day time-course. One possible explanation for this
result would be competition between the co-injected cRNAs for
the oocyte’s translational machinery. However, co-expression of
AmDAT with PfNT1 or EmGFP had no effect on the dopamine
transport activity of AmDAT (Figure 4). The co-expression
of AmDAT with PfNT1 also had no effect on the PfNT1-
mediated transport of hypoxanthine (PfNT1’s major substrate;
Supplementary Figure S5).
Development of a Fluorescence-Based Assay to
Quantitate EmGFP Levels
The expression of EmGFP in oocytes was measured using a
novel fluorescence-based assay. We established that the assay
was quantitative by measuring changes in the magnitude of the
fluorescence signal when oocytes were injected with different
amounts of EmGFP cRNA (ranging from 0 ng to 20 ng;
Supplementary Figure S6). The level of fluorescence measured
in non-injected oocytes (attributable to autofluorescence) was
subtracted from each treatment and the fluorescence intensity
was expressed as a percentage of the value obtained for the
10 ng treatment. A plot of the percent fluorescence intensity
versus the amount of EmGFP cRNA injected produced a
sigmoidal curve that was approximately linear between 0–10 ng
of cRNA (Supplementary Figure S6B). We verified this result
by conducting a western blot analysis of total protein extracts
prepared from oocytes injected with 0–20 ng of EmGFP cRNA.
A band corresponding to the predicted size of EmGFP was
detected with an anti-GFP antibody and the band intensities
were expressed as a percentage of the value obtained for the
10 ng treatment. The resulting plot of protein levels versus
the amount of EmGFP cRNA injected revealed a sigmoidal
relationship that was approximately linear between 0–10 ng
of cRNA (Supplementary Figure S6A). Moreover, there was a
strong correlation (R2 = 0.989) between fluorescence intensity
and EmGFP protein levels in oocytes injected with 0–10 ng of
EmGFP cRNA (Supplementary Figure S6C). Taken together,
these findings confirmed that the fluorescence assay could be used
to quantify the expression of EmGFP in oocytes injected with
0–10 ng of EmGFP cRNA.
AmDAT1ex3 Does Not Inhibit the Translation of
EmGFP
The application of the fluorescence assay revealed no differences
in EmGFP levels between the following treatments on days
1–3 post-cRNA-injection: EmGFP-expressing oocytes (positive
control), oocytes co-expressing EmGFP with AmDAT (co-
injection control), oocytes co-expressing EmGFP with
HAEL2-AmDAT (co-injection control), and oocytes co-
expressing EmGFP with AmDAT1ex3 (p> 0.05; Supplementary
Figure S7). The finding that EmGFP levels were unaffected by
AmDAT1ex3 suggests that the latter’s regulatory effects are
not due to a general inhibition of the oocyte’s translational
machinery. Moreover, the observation that the co-expression
of AmDAT with PfNT1 failed to affect the expression of
either membrane protein suggests that the regulatory effects of
AmDAT1ex3 cannot be attributed to competition with AmDAT
for the ribosomes of the rough endoplasmic reticulum (ER).
AmDAT1ex3 Downregulates the Expression of
AmDAT
We undertook semi-quantitative western blot analyses to
determine the effect of AmDAT1ex3 on the protein levels of
AmDAT. These experiments made use of both the HA-tagged
and non-tagged versions of AmDAT and AmDAT1ex3 (noting
that the HA-tagged proteins exhibit the same [3H]dopamine
transport activities and/or regulatory effects as their non-tagged
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FIGURE 4 | AmDAT1ex3 downregulates the AmDAT-mediated uptake of dopamine in Xenopus oocytes. Measurements of [3H]dopamine transport were performed
on (A) day 1, (B) day 2, and (C) day 3 post-cRNA-injection. Non-injected oocytes (ni) were included as a negative control, EmGFP and PfNT1 were included as
co-injection controls, and oocytes expressing AmDAT served as the positive control. Dopamine uptake was expressed as a percentage of that measured in the
AmDAT-expressing oocytes. The component of [3H]dopamine transport attributable to AmDAT was calculated by subtracting the background level of accumulation
(i.e., dopamine uptake in non-injected oocytes) from that measured for each of the other oocyte types (the total levels of [3H]dopamine uptake are presented in
Supplementary Figure S4). In all panels, the data are the mean + SEM of 3–10 independent experiments (performed using oocytes from different frogs), within
which measurements were made from 10 oocytes per treatment. ∗∗∗ denotes a significant difference (p < 0.001) from the positive control (one-way ANOVA).
counterparts; Figures 2D, 5A,B). We found that co-expression of
HAEL2-AmDAT with AmDAT1ex3 caused a marked reduction
in the level of HAEL2-AmDAT protein relative to that measured
in oocytes expressing only HAEL2-AmDAT (the positive control)
(Figure 5C and Supplementary Figure S8). By contrast, co-
expression of HAEL2-AmDAT with PfNT1 or EmGFP had no
impact on HAEL2-AmDAT protein levels. The down-regulatory
effect of AmDAT1ex3 was evident on both days 1 and 3 post-
cRNA-injection (Figures 5C–E) and was not due to uneven
sample loading and/or uneven transferral of proteins from
the SDS-PAGE gel (Supplementary Figure S9). Moreover, the
expression of AmDAT1ex3 or HAEL2-AmDAT1ex3 did not
affect the overall level of protein in the membrane preparations
(Supplementary Figures S9A–C), which indicates that the splice
variant does not significantly alter the levels of endogenous
membrane proteins. Taken together, these observations reveal
that the splice variant reduces the expression of AmDAT, that this
decrease is evident at the protein level, and cannot be attributed
to competition for ER ribosomes or a general inhibition of the
oocyte’s translational machinery. It is also worth noting that there
was a marked reduction in the level of HAEL2-AmDAT1ex3
protein in oocytes expressing AmDAT + HAEL2-AmDAT1ex3
relative to that measured in oocytes expressing only HAEL2-
AmDAT1ex3 (Figures 5F,G). That is, the expression of both
the full-length protein and its splice variant are significantly
decreased in oocytes co-expressing AmDAT with AmDAT1ex3.
Expression of amdat and amdat1ex3 in
the Honey Bee
Having established that AmDAT is a dopamine transporter
and that AmDAT1ex3 can downregulate its expression in the
oocyte system, we used qPCR to evaluate the expression of
amdat and its splice variant in female castes and drones. These
analyses confirmed our in silico findings that both the full-
length transcript and amdat1ex3 are expressed in adult brains,
antennae, and queen ovaries. However, the amdat1ex3 transcript
level is generally very low relative to the level of amdat transcript
(Supplementary Figure S10).
Given the high level of genetic diversity within the honey
bee colony arising from the queen’s polyandry, as well as the
expectation that AmDAT will be important for social behavior,
we reasoned that gene expression in individual honey bees may
be a more informative approach for evaluating the dynamics of
the two amdat transcripts. Indeed, variability in gene expression
between honey bee workers might be one way by which task-
specialization occurs, including queen-worker communications.
To assess amdat:amdat1ex3 expression in individual bees (age-
matched), we used brains extracted from newly emerged bees and
older foragers. As shown in Figure 6, the levels of both transcripts
were highly variable between the brains of individual worker bees.
However, the relative expression of amdat versus amdat1ex3
appears to be maintained at a similar level, with the full-length
transcript always being the predominant form. Although we
were unable to uncover a clear correlation between the level of
amdat1ex3 transcript and a specific situation in this study, the
finding that this splice variant is always present at low frequencies
in the brain and in some other tissues (Supplementary Table S3)
indicates that it is likely to fulfill an important physiological role.
In situ hybridization with an amdat antisense probe produced
a highly localized signal around a few clusters of neurons in the
honey bee brain, thus confirming the expression of amdat in
cells inferred to be involved in dopaminergic transmission on the
basis of staining with anti-dopamine (Schäfer and Rehder, 1989;
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FIGURE 5 | AmDAT1ex3 downregulates AmDAT protein levels in Xenopus oocytes. The AmDAT-mediated transport of [3H]dopamine in oocytes expressing the
HA-tagged forms of AmDAT or AmDAT1ex3 was measured on (A) day 1 and (B) day 3 post-cRNA-injection. Non-injected oocytes (ni) were included as a negative
control, EmGFP and PfNT1 were included as co-injection controls, and oocytes expressing AmDAT served as the positive control. Dopamine uptake was expressed
as a percentage of that measured in the AmDAT-expressing oocytes. In both panels, the data are the mean + SEM of 3–6 independent experiments (performed
using oocytes from different frogs), within which measurements were made from 10 oocytes per treatment. The capacity of HAEL2-AmDAT for dopamine transport,
and the ability of HAEL2-AmDAT1ex3 to downregulate AmDAT, did not differ significantly from that of its non-tagged counterpart (p > 0.05), consistent with the
HA-tag exerting little or no effect upon the functions of these proteins. (C) Detection of the HAEL2-AmDAT (∼55 kDa band indicated by black arrow) and
HAEL2-AmDAT1ex3 (∼50 kDa band indicated by black arrow) proteins in oocyte membrane preparations. These western blot analyses were performed pairwise
with the transport assays presented in panel (A). The samples were separated on a SDS-polyacrylamide gel and probed with a mouse anti-HA antibody. The image
is representative of >3 independent experiments (performed using oocytes from different frogs) and is shown in full in Supplementary Figure S8.
Semi-quantification of the (D,E) HAEL2-AmDAT and (F,G) HAEL2-AmDAT1ex3 proteins in the oocyte membrane preparations was performed on day 1 panels (D,F)
and day 3 panels (E,G) post-cRNA-injection. Protein band intensities were expressed as a percentage of that measured for the relevant positive control (i.e., oocytes
expressing either HAEL2-AmDAT or HAEL2-AmDAT1ex3). The data in panels (D–G) are shown as the mean + SEM from 3–8 independent experiments. ∗∗∗ denotes
a significant difference (p < 0.001) from the relevant positive control (one-way ANOVAs).
Schürmann et al., 1989) and with anti-tyrosine hydroxalase
antibodies (Schäfer and Rehder, 1989; Schürmann et al., 1989;
Tedjakumala et al., 2017; Supplementary Figure S11).
Methylation of the amdat Locus Implies
Epigenetic Regulation of the Transporter
Standard genome-wide profiling of DNA methylation in the
honey bee brain suggested that there is very little methylation
in the amdat locus, with just a single methyl-cytosine detected
at the 3′ end (CpG#11 in Figure 1A). However, since only
three out of the 14 SLC6 transporters encoded in the honey bee
genome show signs of methylation, this observation suggested
that epigenomic modifications may have been adopted to
regulate the expression of these three transporters. This very
low frequency of methyl-cytosine, which is consistent with a
restricted spatial- or temporal-pattern of methylation, makes it
difficult to draw conclusions about the methylation dynamics
of amdat from genome-wide, low-coverage methylomic profiles.
To overcome this problem, we used gene-focused, ultra-
deep amplicon sequencing. This approach yields thousands
of long-reads corresponding to the region of interest and
allows visualization of the levels, as well as the patterns, of
methylation in individual cell types within the honey bee brain
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FIGURE 6 | Interindividual variability in the expression of the amdat and amdat1ex3 transcripts. RNAs extracted from single brains were used for qPCR evaluation.
Ten individuals were analyzed in each experiment. Refer to the Supplementary Material for further details.
(Becker et al., 2016; Wedd et al., 2016). The analysis presented
here examined whole brains (nurses and foragers) as well as
forager antennae. Four amplicons encompassing the following
regions were generated from bisulfite-converted DNA: intron
2, intron 3, exon 3, and exons 10–11 (Figure 1A). The results
are summarized in Supplementary Table S4. The sequencing
coverage for the brains was high (72,000 to 129,000 reads per
brain amplicons) and 20,000 reads for the antennae. In all
situations a very low level of amdat methylation was detected;
using a conservative conversion rate of 95%, the level of 5′-
C-phosphate-G-3′ dinucleotide (CpG) methylation in the two
introns and in exons 10–11 was ∼5–8% of all sequence reads
in the whole brain and ∼10% in the antennae (Supplementary
Table S4). No methylation was detected in exon 3. These findings
suggest that the amdat locus is methylated in only a limited
number of neurons, most likely those expressing amdat. Whilst
this finding requires additional confirmation, the methylation
of amdat in non-dopaminergic neurons would have yielded a
much higher proportion of methylated CpGs that the levels
measured here. This observation is in agreement with our
previous work linking DNA methylation to active transcription
(Wedd et al., 2016).
DISCUSSION
Previous studies have highlighted the importance of
dopaminergic transmission in insect sociality, especially in
a most critical aspect of social behavior – the queen-worker
communication system that ensures the functional coherence of
thousands of individuals in a colony (Beggs et al., 2007; Vergoz
et al., 2007). The involvement of dopamine in the pheromonal
control of worker bees is well documented, as is the correlation
between changes in the concentration of dopamine and the
progression of worker behaviors (Jarriault and Mercer, 2012).
Here we have addressed a fundamental gap in our understanding
of the honey bee dopaminergic system by identifying an Apis
mellifera dopamine transporter as well as an unusual splice
variant of this protein, and through conducting in-depth
characterizations of their expression and functions.
When expressed in the Xenopus oocyte system, both the
non-tagged and HA-tagged versions of full-length AmDAT
cause a substantial increase in the uptake of dopamine
(∼12-fold increase in dopamine transport relative to non-
injected oocytes). This robust transport signal allows detailed
investigations of the protein’s transport properties. We found
that AmDAT exhibits a high specificity for dopamine and
noradrenaline transport, that it translocates tyramine as a
minor substrate, and does not appear to transport octopamine,
L-Dopa, or serotonin. The finding that the concentration-
dependence of dopamine transport via AmDAT is sigmoidal
suggests that the transporter undergoes allosteric substrate
activation. These transport properties of AmDAT in Xenopus
oocytes, which are similar to those of the Drosophila dopamine
transporter DmDAT (Porzgen et al., 2001), are consistent with
its strong sequence homology to known dopamine transporters
from other species. The crystal structure of DmDAT in
complex with two antidepressants was recently determined
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(Penmatsa et al., 2015), and given the high level of sequence
conservation between AmDAT and DmDAT, the structure of
AmDAT is likely to be very similar (if not identical) to that of
the Drosophila transporter.
We show that cocaine is a reversible inhibitor of AmDAT
and that cocaine itself is not a substrate of the transporter.
These results, which are consistent with the reported effects of
cocaine on dopamine transporters (Lluch et al., 2005; Beuming
et al., 2008; Sullivan et al., 2008), add further support to
our recent identification of a link between cocaine and DNA
methylation dynamics in the honey bee (Sovik et al., 2018).
We showed that cocaine treatment interferes with memory
processing independently of incentive salience by directly altering
DNA methylation dynamics (Sovik et al., 2018) and thus the
expression of methylated genes. Because amdat is methylated,
both its epigenetic status and expression are expected to be
significantly changed by cocaine, thereby leading to dopamine
imbalance. In mammalian brains, many addictive drugs alter
dopaminergic neurotransmission in the midbrain pathway by
either enhancing the release or reducing the clearance of
dopamine (Kuhar et al., 1991; Huang et al., 2009), and thereby
increasing the incentive salience of a given stimuli (Berridge,
2007). Cocaine induces widespread changes in DNA methylation
patterns in the mammalian brain (Nestler, 2014), which is of
particular interest given that DNA methyltransferases (DNMTs)
and demethylases are vital for memory formation in both
mammals and honey bees (Barron et al., 2009; Lockett et al.,
2010, 2012; Day and Sweatt, 2011; Wojciechowski et al., 2014).
Because the impact of cocaine on behavior and neurochemical
responses in bees and mammals are comparable (Barron et al.,
2009; Sovik et al., 2018), this insect presents a valuable
system by which to explore the basic interactions between
drugs of abuse, epigenomic modifications, and animal behavior
(Maleszka, 2016).
We find amdat to be predominantly expressed in the brain
and antennae, but the presence of RNAseq reads in other tissue
samples indicate that dopamine has roles outside the nervous
system – including in the ovaries and glands. In comparison to
the full-length mRNA, the expression of amdat1ex3 is low and
represents approximately 1% of the combined transcription. In
age-matched individual bees, the expression of both transcripts
in the brain is quite variable, which may be driven by
genetic or epigenetic polymorphisms (Maleszka, 2016; Wedd
and Maleszka, 2016; Wedd et al., 2016). Whether or not such
variability in amdat and amdat1ex3 expression is advantageous
for social organization remains to be established, but it is
conceivable that it could lead to differences in dopaminergic
neurotransmission and thus differences in behavior. This is
an area that has not been explored in honey bees or in
other social insects, but some insights could be gained from
mammalian research. For example, polymorphisms in the human
DAT genes (e.g., HsDAT1) have been reported and associated
with variations in susceptibilities to neurobiological disorders
(Roman et al., 2004).
Our discovery and characterization of the AmDAT1ex3 splice
variant adds to the growing number of alternatively spliced
transporters that have been shown to modulate the function
of their full-length counterparts. For example, several naturally
occurring splice variants of mammalian transporters have been
reported to exert a dominant-negative effect on their full-
length isoforms (Kitayama et al., 1999; Vallejo-Illarramendi
et al., 2005; Gebhardt et al., 2010; Sogawa et al., 2010; De
Bellis et al., 2014). Like AmDAT1ex3, these alternatively
spliced transcripts are missing one or more exons from their
respective full-length sequences and are hence predicted to
encode proteins with grossly deformed topologies. Moreover,
thus far the majority of these splice variants are isoforms
of mammalian neurotransmitter transporters, including the
noradrenaline transporter (NET), DAT, and excitatory amino
acid transporters 1 and 2 (EAAT1 and EAAT2, respectively).
These studies have proposed a regulatory mechanism involving
the formation of unstable heteromeric complexes, formed by
the splice variant and full-length proteins, that are retained
in the ER and targeted for degradation (Gebhardt et al.,
2010; Sogawa et al., 2010; De Bellis et al., 2014). The
expression of AmDAT1ex3 may likewise cause AmDAT
to be retained in the ER and targeted for degradation,
but we cannot rule out the possibility that amdat1ex3
instead acts by inducing the degradation of the full-length
amdat transcript.
The presence of amdat1ex3 transcripts in virtually all honey
bee RNAseq libraries (albeit at low levels) suggests it has a
physiological role. Although the mechanism underpinning
the regulatory activity of AmDAT1ex3 remains unresolved, it
is possible that its activity is not limited to the modulation
of full-length AmDAT. For example, the splice variant
of rat NET was found to downregulate the expression of
several rat neurotransmitter transporters – including DAT,
other monoamine transporters, and the GABA transporter
type 1 – but appeared to have no effect on EAAT1 (also
known as GLAST) (Kitayama et al., 1999). Given the
sequence similarities between the NET and DAT proteins,
it is possible that the physiological role of AmDAT1ex3
is to fine-tune the expression of AmDAT, and potentially
other neurotransmitter transporters, via a mechanism that
bypasses the more elaborate and expensive process of de
novo transcription and translation of distinct regulatory
proteins. This may enable more rapid cellular responses to
developmental and/or environmental cues. The benefits of this
mechanism for social interaction, which are often based on subtle
threshold responses (Johnson, 2003; Jeanson and Weidenmuller,
2014; Wedd et al., 2017), could be plentiful. Hence, our
demonstration of AmDAT1ex3’s ability to downregulate the
expression of AmDAT in vitro is a significant result that merits
further investigation.
Our epigenetic analyses show that the amdat locus is modified
by the methylation of cytosines in two introns and one exon
(altogether a total of ten CpGs). Only two of the remaining
13 SLC6 transporter genes in the honey bee genome show
signs of methylation (Supplementary Table S2). Using the ultra-
deep amplicon sequencing approach, we found that the ten
CpGs are methylated at ∼5–10% in whole-brain or antennae
extracts. This result suggests that amdat is methylated in
only a small proportion of cells. One possibility is that these
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cells correspond to dopaminergic neurons that consist of four
small clusters in the honey bee brain [(Schäfer and Rehder,
1989; Schürmann et al., 1989; Tedjakumala et al., 2017) and
(Supplementary Figure S11)]. Similarly, only the cells involved
in dopaminergic communication in the antennae would carry
methylated copies of amdat. These findings provide indirect
support for the view that DNA methylation in the honey bee
is associated with active transcription rather than repression
(Kucharski et al., 2016; Wedd and Maleszka, 2016; Wedd et al.,
2016; Welsh et al., 2017). It is worth noting that in the honey
bee genome-wide methylomic datasets that were generated at
low depth, only a single methylated CpG#11 is documented in
the amdat locus (Lyko et al., 2010). Hence, an important insight
gained from this study is that the epigenomic architecture of the
dopaminergic (and similar) systems in the honey bee should be
studied at the level of specific cell groups, rather than whole-
brain extracts, when applying a low-depth sequencing approach.
Whilst methylomic variations in the promoter region of the
human DAT1 gene (SLC6A3) have been reported to affect DAT
expression, these findings are of limited relevance to the honey
bee because it is the gene bodies – not the promoters – that are
methylated in insect genomes. Moreover, promoter methylation
in mammals is associated with transcription repression, rather
than its activation (Ziller et al., 2013).
Given the small number of clustered dopaminergic neurons
in the honey bee brain, the whole-brain transcriptome or
epigenome profiles are poor indicators of the biological relevance
of AmDAT. This important aspect of brain research in honey
bees, and other organisms, was emphasized in the context of
dopamine receptors whose age-related expression in worker
brains was found to differ depending on the functionally diverse
groups of cells within the mushroom body neuropil (McQuillan
et al., 2012). These and other findings (Maleszka, 2016) bring
into focus the need to move beyond conventional analyses
by developing cell-type-specific approaches at high depth to
uncover the conditions affecting differential gene expression or
methylation in defined neuronal populations, and how these
dynamic processes affect brain circuitry and behavior.
Our study has generated important insights into the
transciptome-epigenome-protein-level control of an important
transporter that has been implicated in social behavior. Although
many features of AmDAT are conserved, we have uncovered
novel properties that distinguish the honey bee protein from its
close homologs in insects and other organisms. These include
the methylation of amdat, which is not possible in Drosophila
or in the many other insect and invertebrate species that lack
all (or some) of the components of epigenetic machinery (Lyko
and Maleszka, 2011; Wedd and Maleszka, 2016). Importantly,
our discovery of a non-transporting variant capable of reducing
the expression of full-length AmDAT implies an additional level
of regulation that could impact other neuromodulatory circuits
interacting with dopaminergic transmission. When combined
with a significant level of inter-individual variability of amdat
expression, the multiple levels of control could contribute to
subtle behavioral adjustments that are an important feature of
eusociality (Maleszka et al., 2014; Maleszka, 2016, 2018). In a
broader context this work reinforces the utility of the honey
bee in modeling the extent to which intricate cellular networks
can be used to reshape phenotypic outcomes. Our findings
encourage new avenues of research that seek to understand how
social interactions are being driven by lineage-specific tuning of
otherwise conserved signaling pathways.
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